Please provide your email address to receive an email when new articles are posted on . “Patients with ILD are at an elevated risk of developing lung cancer across all subtypes, especially rare and ...

Isolated antineutrophil cytoplasmic antibody-associated interstitial lung disease is an increasingly recognized fibrotic ILD phenotype.

RA-ILD significantly increases mortality, with a median survival of less than 3 years post-diagnosis. Key risk factors include male gender, older age, smoking, pulmonary comorbidities, rheumatoid ...

Lung ultrasound is effective for detecting ILD in RA patients, with high sensitivity and moderate specificity. B-lines are a primary criterion for ILD diagnosis in LUS, indicating pulmonary ...

Patients with rheumatoid arthritis (RA) face increased risk for interstitial lung disease (ILD) and comorbidities appear to raise it further. This retrospective study sought to compare different ...

Chinese researchers have developed a new a circulating exosomal proteomic biomarker signature that may aid in the diagnosis of interstitial lung disease (ILD) in combination with computed tomography.

Specific combinations of CT imaging features rather than individual findings alone may improve the accuracy of identifying ...

The prevalence of interstitial lung disease (ILD) across connective tissue disorders (CTDs) and its persistent standing as a leading cause of death in patients with CTDs challenge rheumatologists to ...

The time interval between onset of interstitial lung disease (ILD) and diagnosis of anti–melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis (DM) "has not been well ...

“Progressive pulmonary fibrosis is linked to underlying clinical ILD diagnoses including autoimmune ILDs – which can be caused by disorders like rheumatoid arthritis or systemic sclerosis – as well as ...